2017-12-21 · NDA208374
Bivalirudin
bivalirudin · original submission 1 · status AP.
Open full application timeline →Open selected original record →
FDA application source year
21 selected records whose approved original-submission status date falls in 2017. Dates and status codes are attributed to the retained official dataset observation.
2017-12-21 · NDA208374
bivalirudin · original submission 1 · status AP.
Open full application timeline →2017-12-05 · NDA209637
semaglutide · original submission 1 · status AP.
Open full application timeline →2017-11-22 · ANDA206551
bivalirudin · original submission 1 · status AP.
Open full application timeline →2017-11-06 · ANDA205557
eptifibatide · original submission 1 · status AP.
Open full application timeline →2017-10-20 · NDA209210
exenatide synthetic · original submission 1 · status AP.
Open full application timeline →2017-10-20 · NDA209949
daptomycin · original submission 1 · status AP.
Open full application timeline →2017-10-03 · ANDA091345
desmopressin acetate · original submission 1 · status AP.
Open full application timeline →2017-10-03 · ANDA091646
glatiramer acetate · original submission 1 · status AP.
Open full application timeline →2017-10-03 · ANDA206936
glatiramer acetate · original submission 1 · status AP.
Open full application timeline →2017-09-12 · NDA208385
daptomycin · original submission 1 · status AP.
Open full application timeline →2017-08-22 · ANDA204695
desmopressin acetate · original submission 1 · status AP.
Open full application timeline →2017-08-22 · ANDA204751
desmopressin acetate · original submission 1 · status AP.
Open full application timeline →2017-07-06 · ANDA204876
bivalirudin · original submission 1 · status AP.
Open full application timeline →2017-06-29 · NDA208956
triptorelin pamoate · original submission 1 · status AP.
Open full application timeline →2017-05-26 · ANDA201577
bivalirudin · original submission 1 · status AP.
Open full application timeline →2017-05-26 · ANDA207880
desmopressin acetate · original submission 1 · status AP.
Open full application timeline →2017-04-28 · NDA208743
abaloparatide · original submission 1 · status AP.
Open full application timeline →2017-04-18 · ANDA204589
eptifibatide · original submission 1 · status AP.
Open full application timeline →2017-03-03 · NDA201656
desmopressin acetate · original submission 1 · status AP.
Open full application timeline →2017-02-07 · NDA208325
etelcalcetide · original submission 1 · status AP.
Open full application timeline →2017-01-19 · NDA208745
plecanatide · original submission 1 · status AP.
Open full application timeline →